2552 — Hua Medicine Income Statement
0.000.00%
Last trade - 00:00- HK$1.47bn
- HK$69.08m
- CNY76.61m
Annual income statement for Hua Medicine, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 17.6 | 76.6 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | 7.69 | 37.4 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 424 | 389 | 322 | 217 | 280 |
| Operating Profit | -424 | -389 | -322 | -200 | -203 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -425 | -393 | -326 | -204 | -211 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -425 | -393 | -326 | -204 | -211 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -425 | -393 | -326 | -204 | -211 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -425 | -393 | -326 | -204 | -211 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.451 | -0.417 | -0.341 | -0.211 | -0.216 |